These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3522924)

  • 1. Plasma levels and urinary excretion of batroxobin and its defibrinogenating effects in various animal species.
    Sugai K; Imamura Y; Mihashi S; Ohba M; Kunikane K; Mori N; Baba S
    J Toxicol Sci; 1986 May; 11(2):135-43. PubMed ID: 3522924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic fate of 125I-labeled batroxobin in rats and dogs.
    Sugai K; Imamura Y; Mihashi S; Mori N; Baba S
    J Toxicol Sci; 1986 Aug; 11(3):155-67. PubMed ID: 3540318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of the sandwich enzyme immunoassay for determination of batroxobin in various animal plasma].
    Sugai K; Imamura Y; Mihashi S; Mori N; Baba S
    Yakugaku Zasshi; 1986 Apr; 106(4):330-4. PubMed ID: 3525812
    [No Abstract]   [Full Text] [Related]  

  • 4. Defibrinogenation with benzoyl-batroxobin.
    Markwardt F; Paintz M; Richter M; Stürzebecher J
    Thromb Res; 1985 Oct; 40(1):41-7. PubMed ID: 3911486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defibrinogenating effect of batroxobin (Defibrase) in rats and inhibition of migration of human vascular smooth muscle cells by the plasma of batroxobin-treated rats in vitro.
    Wang DS; Hanamoto M; Fang F; Ohba M; Ishii M; Kimura F; Higaki E; Senga H
    Atherosclerosis; 2001 May; 156(1):73-80. PubMed ID: 11368999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hypofibrinogenemia with batroxobin on rat Masugi nephritis.
    Tomita K; Muso E; Tamura T; Kawai C
    Jpn Circ J; 1982 Jun; 46(6):577-82. PubMed ID: 7045444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defibrinogenation by batroxobin and acylated batroxobin in rats.
    Richter M; Paintz M; Stürzebecher J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):147-51. PubMed ID: 2459010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of batroxobin with activated polyethylene glycol: reduction of binding ability towards anti-batroxobin antibody and retention of defibrinogenation activity in circulation of preimmunized dogs.
    Nishimura H; Takahashi K; Sakurai K; Fujinuma K; Imamura Y; Ooba M; Inada Y
    Life Sci; 1983 Oct; 33(15):1467-73. PubMed ID: 6353117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic fate of batroxobin in human].
    Sugai K; Imamura Y; Uechi S; Namikata S; Mihashi S; Mori N; Hada M; Kurosoh K; Ukita M; Fukutake K
    Yakugaku Zasshi; 1986 Apr; 106(4):335-42. PubMed ID: 3525813
    [No Abstract]   [Full Text] [Related]  

  • 10. Defibrinogenating enzymes.
    Bell WR
    Drugs; 1997; 54 Suppl 3():18-30; discussion 30-1. PubMed ID: 9360849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic disposition of 6-ethyl-3-(1H-tetrazol-5-yl)-chromone, a new antiallergic agent, in the rat, guinea-pig, rabbit, dog and monkey.
    Kanai Y; Nakai Y; Nakajima N; Tanayama S
    Xenobiotica; 1979 Jan; 9(1):33-50. PubMed ID: 104449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of defibrinogenation with batroxobin on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T; Murakami M; Furukawa Y; Takemura S; Kato H; Kondo M
    Thromb Res; 1983 Sep; 31(5):729-35. PubMed ID: 6359574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics of SCE-2787 and related antibiotics in experimental animals.
    Kita Y; Yamazaki T; Imada A
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2481-6. PubMed ID: 1489192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species differences in enantioselective 2-oxidations of RS-8359, a selective and reversible MAO-A inhibitor, and cinchona alkaloids by aldehyde oxidase.
    Itoh K; Yamamura M; Takasaki W; Sasaki T; Masubuchi A; Tanaka Y
    Biopharm Drug Dispos; 2006 Apr; 27(3):133-9. PubMed ID: 16400710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of renal excretion of carumonam in rats, rabbits, dogs, and monkeys.
    Kita Y; Imada A
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1692-6. PubMed ID: 3435117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of the inodilator XB513 in mice, rats, guinea pigs, rabbits, dogs, and monkeys.
    Stampfli HF; Person CR; Huang SM; Quon CY
    Biopharm Drug Dispos; 1994 Dec; 15(9):789-93. PubMed ID: 7888606
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma administration to defibrinogenated dogs during extracorporeal circulation.
    Berglin E; Hansson HA; William-Olsson G
    Artif Organs; 1979 Feb; 3(1):80-5. PubMed ID: 435130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of batroxobin on cochlear blood flow.
    Kawakami M; Makimoto K; Yamamoto H; Takahashi H
    Acta Otolaryngol; 1992 Nov; 112(6):991-7. PubMed ID: 1481670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacodynamics and pharmacokinetics of batroxobin in Beagle dog].
    Zheng ZH; Zhu XX; Gan H; Gu RL; Wu ZN; Meng ZY; Dou GF
    Yao Xue Xue Bao; 2013 Aug; 48(8):1307-11. PubMed ID: 24187841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin-like snake venom proteinases.
    Stocker K; Fischer H; Meier J
    Toxicon; 1982; 20(1):265-73. PubMed ID: 7043783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.